Richard Graham
2023
In 2023, Richard Graham earned a total compensation of $1.4M as Former Senior Vice President, Strategic Advisor R&D at Theravance Biopharma, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $130,000 |
|---|---|
| Salary | $518,333 |
| Stock Awards | $753,000 |
| Other | $5,000 |
| Total | $1,406,333 |
Graham received $753K in stock awards, accounting for 54% of the total pay in 2023.
Graham also received $130K in non-equity incentive plan, $518.3K in salary and $5K in other compensation.
Rankings
In 2023, Richard Graham's compensation ranked 846th out of 3,006 executives tracked by ExecPay. In other words, Graham earned more than 71.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 846 out of 3,006 | 72nd |
Division Manufacturing | 494 out of 1,650 | 70th |
Major group Chemicals And Allied Products | 336 out of 918 | 63rd |
Industry group Drugs | 327 out of 881 | 63rd |
Industry Pharmaceutical Preparations | 219 out of 637 | 66th |
Source: SEC filing on April 5, 2024.
Graham's colleagues
We found two more compensation records of executives who worked with Richard Graham at Theravance Biopharma in 2023.